We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+1.54%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.84B
AUM Growth
+$1.62B
(+22%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
19.13%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
656
New
169
Increased
202
Reduced
101
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rithm Capital
RITM
|
+$78.4M |
| 2 |
Infosys
INFY
|
+$65M |
| 3 |
F5
FFIV
|
+$64.6M |
| 4 |
Western Digital
WDC
|
+$62.1M |
| 5 |
Cigna
CI
|
+$60.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$69.1M |
| 2 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$68.2M |
| 3 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$57.6M |
| 4 |
Medtronic
MDT
|
+$51.8M |
| 5 |
DRC
DRESSER-RAND GROUP INC
DRC
|
+$50.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.28% |
| 2 | Healthcare | 13.44% |
| 3 | Technology | 12.36% |
| 4 | Financials | 10.47% |
| 5 | Energy | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Xencor
XNCR
$1.55B
| $4.63M | 0.05% |
210,504
-150,561
| -42% | -$2.57M |
|
|
POT
277
DELISTED
Potash Corp Of Saskatchewan
POT
| $4.6M | 0.05% |
+148,614
| New | +$4.76M |
|
|
MB
278
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $4.58M | 0.05% |
+330,924
| New | +$4.47M |
|
|
HMTV
279
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $4.46M | 0.05% |
+374,409
| New | +$4.67M |
|
|
SNAK
280
DELISTED
Inventure Foods, Inc.
SNAK
| $4.41M | 0.05% |
434,654
+232,186
| +115% | +$2.38M |
|
|
JCAP
281
DELISTED
Jernigan Capital, Inc.
JCAP
| $4.33M | 0.05% |
213,292
+154,674
| +264% | +$3.25M |
|
|
CALD
282
DELISTED
Callidus Software, Inc.
CALD
| $4.27M | 0.05% |
273,781
-76,219
| -22% | -$1.09M |
|
283
GoDaddy
GDDY
$11.5B
| $4.23M | 0.05% |
+150,000
| New | +$4.07M |
|
|
OMED
284
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $4.22M | 0.05% |
187,585
+28,034
| +18% | +$691K |
|
|
FENX
285
DELISTED
Fenix Parts, Inc.
FENX
| $4.22M | 0.05% |
+421,044
| New | +$4.4M |
|
286
Unum
UNM
$14.3B
| $4.18M | 0.05% |
117,049
+23,374
| +25% | +$817K |
|
|
UNVR
287
DELISTED
Univar Solutions Inc.
UNVR
| $4.15M | 0.05% |
+159,351
| New | +$4.2M |
|
288
Eledon Pharmaceuticals
ELDN
$285M
| $4.08M | 0.05% |
1,892
+138
| +8% | +$267K |
|
289
Vince Holding Corp
VNCE
$86.8M
| $4.02M | 0.05% |
33,540
+18,080
| +117% | +$3.03M |
|
290
A10 Networks
ATEN
$1.95B
| $4.01M | 0.05% |
+622,147
| New | +$3.48M |
|
|
MPG
291
DELISTED
Metaldyne Performance Group Inc.
MPG
| $3.98M | 0.05% |
219,267
-238,439
| -52% | -$4.52M |
|
|
EHIC
292
DELISTED
eHi Car Services Limited
EHIC
| $3.98M | 0.05% |
275,000
-125,000
| -31% | -$1.66M |
|
293
Darling Ingredients
DAR
$9.44B
| $3.94M | 0.04% |
268,504
-31,284
| -10% | -$461K |
|
|
NORD
294
DELISTED
Nord Anglia Education, Inc.
NORD
| $3.91M | 0.04% |
+159,305
| New | +$3.99M |
|
|
INFO
295
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $3.84M | 0.04% |
+150,000
| New | +$3.96M |
|
|
ACGN
296
DELISTED
Aceragen Inc
ACGN
| $3.79M | 0.04% |
7,519
+121
| +2% | +$55.5K |
|
297
TransUnion
TRU
$15.3B
| $3.77M | 0.04% |
+150,000
| New | +$3.74M |
|
298
Unisys
UIS
$217M
| $3.76M | 0.04% |
+188,218
| New | +$4.05M |
|
|
EPZM
299
DELISTED
Epizyme, Inc
EPZM
| $3.67M | 0.04% |
153,124
-196,876
| -56% | -$3.79M |
|
300
Walker & Dunlop
WD
$1.53B
| $3.6M | 0.04% |
134,649
-813,702
| -86% | -$18.1M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2015 Portfolio in Review
As of Q2 2015, Alyeska Investment Group held 656 positions worth $8.84B, up 22% from $7.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Alyeska Investment Group deployed $1.69B of net new capital in Q2 2015, opening 169 new positions and adding to 202 existing holdings. Its largest new stake was Infosys: 8,002,538 shares worth $63.4M.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Ciena, an estimated $33.5M trimmed.
- Alyeska Investment Group's largest Q2 2015 buy was Infosys: 8,002,538 shares worth $63.4M.
- Alyeska Investment Group added most to Rithm Capital in Q2 2015, an estimated $78.4M increase.
- Alyeska Investment Group's biggest Q2 2015 reduction was Ciena, cutting an estimated $33.5M.
- Alyeska Investment Group fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $69.1M.
- Alyeska Investment Group's ten largest holdings make up 18% of its $8.84B portfolio in Q2 2015.
- Alyeska Investment Group opened 169 new positions and closed 175 in Q2 2015.
- Alyeska Investment Group's portfolio value rose 22% quarter-over-quarter to $8.84B.
Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.